![]() |
Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints...
More... |
| All times are GMT -7. The time now is 11:52 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021